1
|
Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase.
|
Proc Natl Acad Sci U S A
|
2007
|
3.27
|
2
|
Characterization of Alisertib (MLN8237), an investigational small-molecule inhibitor of aurora A kinase using novel in vivo pharmacodynamic assays.
|
Clin Cancer Res
|
2011
|
2.35
|
3
|
Localization of human TACC3 to mitotic spindles is mediated by phosphorylation on Ser558 by Aurora A: a novel pharmacodynamic method for measuring Aurora A activity.
|
Cancer Res
|
2007
|
1.62
|
4
|
Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes.
|
Clin Cancer Res
|
2004
|
1.42
|
5
|
Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction.
|
Proc Natl Acad Sci U S A
|
2003
|
1.14
|
6
|
MLN8054, an inhibitor of Aurora A kinase, induces senescence in human tumor cells both in vitro and in vivo.
|
Mol Cancer Res
|
2010
|
1.11
|